Brief: NanoCarrier says basic agreement on international joint development of NC-6004 to treat head and neck cancer
15/05/2018 12:07
May 15 (Reuters) - NanoCarrier Co Ltd 4571.T
* Says it entered into an agreement with the NC-6004
out-licensee,
Orient Europharma Co Ltd 4120.TWO , aimed at the Asian region,
to integrate clinical development of NC-6004 for the treatment
of head and neck cancer
* Says two entities will conclude a basic agreement for
additional
licensing and joint development of NC-6004 in regions such as
Europe and the United States
Source text in Japanese: https://goo.gl/EdKeJX
Further company coverage: 4571.T 4120.TWO
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: Tingting.liu@thomsonreuters.com@reuters.net))